Randomized Double-blind Trials of Jingyuankang Capsule on Peripheral Blood Leukocyte in HIV/AIDS Cases

JIANG Shi-qing1; SUN Hong-xin2; XU Ying-min1; PEI Jun-wen3; WANG Hong-ling1

doi:10.13422/j.cnki.syfjx.2010.14.005

您当前的位置：

首页 >

文章列表页 >

Randomized Double-blind Trials of Jingyuankang Capsule on Peripheral Blood Leukocyte in HIV/AIDS Cases

更新时间：2024-09-23

- Randomized Double-blind Trials of Jingyuankang Capsule on Peripheral Blood Leukocyte in HIV/AIDS Cases
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 16, Issue 14, Pages: 201-203(2010)
- 作者机构：
  
  1. 河南中医学院
  2. 河南省中医院
  3. 河南省肿瘤医院
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2010.14.005
  CLC： R259
- Published：2010
- 稿件说明：
移动端阅览
[1]蒋士卿,孙宏新,徐英敏,裴俊文,王红玲.精元康胶囊对不同治疗方案的116例HIV/AIDS患者白细胞水平影响的随机对照研究[J].中国实验方剂学杂志,2010,16(14):201-203+206.

JIANG Shi-qing1, SUN Hong-xin2, XU Ying-min1, et al. Randomized Double-blind Trials of Jingyuankang Capsule on Peripheral Blood Leukocyte in HIV/AIDS Cases[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(14): 201-203.
[1]蒋士卿,孙宏新,徐英敏,裴俊文,王红玲.精元康胶囊对不同治疗方案的116例HIV/AIDS患者白细胞水平影响的随机对照研究[J].中国实验方剂学杂志,2010,16(14):201-203+206. DOI： 10.13422/j.cnki.syfjx.2010.14.005.

JIANG Shi-qing1, SUN Hong-xin2, XU Ying-min1, et al. Randomized Double-blind Trials of Jingyuankang Capsule on Peripheral Blood Leukocyte in HIV/AIDS Cases[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(14): 201-203. DOI： 10.13422/j.cnki.syfjx.2010.14.005.

摘要

目的:观察精元康胶囊对艾滋病外周血象低下的治疗效果。方法:选用中药制剂精元康胶囊+利可君片模拟剂与HAART疗法同时服用组患者58例

并与西药利可君片+精元康胶囊模拟剂与HAART疗法同时服用患者58例

采用随机、双盲、双模拟剂的临床试验方法

均系统服药6个月

定期检测患者外周血象

以观察精元康胶囊对艾滋病不同程度的白细胞低下的治疗效果。结果:精元康胶囊治疗艾滋病外周血象低下效果良好

服用含齐多夫定（AZT）HAART方案的患者与服用不含齐多夫定（AZT）的HAART方案者比较

均显示出提升白细胞作用。精元康胶囊临床安全有效

治疗中及后期随访均未观察到本制剂引起的毒副作用和不良反应。结论:精元康胶囊可有效治疗艾滋病患者外周血象低下。

Abstract

Objective:To observe the the therapeutic effect on peripheral blood leukocyte reduction of AIDS by Jingyuankang Capsule.Method:116 cases of HIV /AIDS patients were divided into two groups:58 cases in the treatment were treated by Jingyuankang Capsule and likejun mimic tablet with HAART therapy

and the other 58 cases in the control by likejun tablet and mimic Jingyuankang Capsules with HAART.The design was a randomized double-blind research

and 6 months as a course.Peripheral blood leukocytes were monitored for these cases.Result:Jingyuankang Capsule treatment for AIDS showed good effect

whether they had taken with AZT（HAART） or not.HAART scheme showed that it could improve peripheral blood leukocytes.Jingyuankang Capsule appeared safe and effective.Through clinical investigation and follow-up the capsule showed no toxicity and adverse reaction.Conclusion:Jingyuankang Capsules can effectively treat AIDS patients with reduction in peripheral blood leukocyte.

关键词

Keywords

references

Views

224

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Related Author

JIANG Shi-qing

SUN Hong-xin

XU Ying-min

PEI Jun-wen

WANG Hong-ling

Related Institution

No data

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰